Literature DB >> 23632149

Screening and surgical outcomes of familial pancreatic cancer.

Adam W Templeton1, Teresa A Brentnall.   

Abstract

This article reviews the genetics and incipient pathology of familial pancreatic cancer and the screening modalities in current use, and summarizes the outcomes of reported screening programs.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23632149     DOI： 10.1016/j.suc.2013.02.002

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  15 in total

1.  Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.

Authors:  Pari V Pandharipande; Curtis Heberle; Emily C Dowling; Chung Yin Kong; Angela Tramontano; Katherine E Perzan; William Brugge; Chin Hur
Journal:  Radiology       Date:  2014-11-12       Impact factor: 11.105

Review 2.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Imaging in pancreatic disease.

Authors:  Julien Dimastromatteo; Teresa Brentnall; Kimberly A Kelly
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-09       Impact factor: 46.802

Review 4.  Familial pancreatic cancer.

Authors:  Gloria M Petersen
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

5.  Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival.

Authors:  Jill P Smith; David C Whitcomb; Gail L Matters; Randall E Brand; Jiangang Liao; Yu-Jing Huang; Marsha L Frazier
Journal:  Pancreas       Date:  2015-03       Impact factor: 3.327

6.  Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment.

Authors:  Nicholas Osborne; Rebecca Sundseth; Julian Burks; Hong Cao; Xunxian Liu; Alexander H Kroemer; Lynda Sutton; Allen Cato; Jill P Smith
Journal:  Cancer Immunol Immunother       Date:  2019-09-24       Impact factor: 6.968

7.  Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.

Authors:  Paul F Laeseke; Ru Chen; R Brooke Jeffrey; Teresa A Brentnall; Jürgen K Willmann
Journal:  Radiology       Date:  2015-12       Impact factor: 11.105

Review 8.  Familial Pancreatic Adenocarcinoma.

Authors:  Gloria M Petersen
Journal:  Hematol Oncol Clin North Am       Date:  2015-06-09       Impact factor: 3.722

9.  Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice.

Authors:  Jill P Smith; Timothy K Cooper; Christopher O McGovern; Evan L Gilius; Qing Zhong; Jiangang Liao; Alfredo A Molinolo; J Silvio Gutkind; Gail L Matters
Journal:  Pancreas       Date:  2014-10       Impact factor: 3.327

10.  Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma.

Authors:  Tomasz P Radon; Nathalie J Massat; Richard Jones; Wasfi Alrawashdeh; Laurent Dumartin; Darren Ennis; Stephen W Duffy; Hemant M Kocher; Stephen P Pereira; Luisa Guarner posthumous; Cristiane Murta-Nascimento; Francisco X Real; Núria Malats; John Neoptolemos; Eithne Costello; William Greenhalf; Nick R Lemoine; Tatjana Crnogorac-Jurcevic
Journal:  Clin Cancer Res       Date:  2015-08-01       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.